Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.

Administration; Oral
Adult
Aged
Aged; 80 and over
Anticoagulants/administration & dosage/adverse effects/*therapeutic use
Arthroplasty; Replacement; Hip
Arthroplasty; Replacement; Knee
Azetidines/administration & dosage/adverse effects/*therapeutic use
Benzylamines
Cause of Death
Double-Blind Method
Drug Administration Schedule
Enoxaparin/administration & dosage/adverse effects/*therapeutic use
Female
Glycine/administration & dosage/adverse effects/*analogs & derivatives/*therapeutic use
Hemorrhage/chemically induced
Humans
Injections; Subcutaneous
Male
Middle Aged
Postoperative Complications/*prevention & control
Prodrugs/administration & dosage/adverse effects/therapeutic use
Prospective Studies
Pulmonary Embolism/*prevention & control
Safety
Thrombin/*antagonists & inhibitors
Treatment Outcome
Venous Thrombosis/*prevention & control

Agnelli, Giancarlo (author)
Cohen, Alexander T (author)
Dahl, Ola E (author)
Mouret, Patrick (author)
Rosencher, Nadia (author)
Eskilson, Christina (author)
Nylander, Ingela (author)
Frison, Lars (author)
Ogren, MatsUppsala universitet,Institutionen för kirurgiska vetenskaper,Vascular Surgery (author)
Uppsala universitetInstitutionen för kirurgiska vetenskaper (creator_code:org_t)

By the author/editor: Eriksson, Bengt ...; Agnelli, Giancar ...; Cohen, Alexander ...; Dahl, Ola E; Mouret, Patrick; Rosencher, Nadia; show more...; Eskilson, Christ ...; Nylander, Ingela; Frison, Lars; Ogren, Mats; show less...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.